Hydrus vs istent, hypothesized that a single Hydrus microstent would result in lower intraocular pressure (IOP) and reduced need for glaucoma medication in patients with open-angle glaucoma (OAG) compared to a pair of iStent devices. Dec 15, 2025 · Abstract Aim: To compare the long-term effectiveness of combined phacoemulsification and Hydrus microstent (phaco-Hydrus) versus iStent inject (phaco-iStent) using microinvasive glaucoma surgery-specific surgical success definitions in a large observational cohort. XEN. Jan 5, 2026 · The Hydrus Microstent (HM) and iStent inject W are two widely used trans-trabecular bypass devices and can be combined with phacoemulsification for glaucoma patients undergoing cataract surgery. In this study, compared to minimally invasive devices, the iStent infinite and the Hydrus Microstent, which both were designed to enhance outflow and lower intraocular pressure, this was prospective. They found that the Hydrus resulted in a higher rate of surgical success and less need for glaucoma medication. Traditional Glaucoma Surgery Comparing MIGS Procedures: iStent vs. Patients received one of these MIGS implants with phacoemulsification or standalone phacoemulsification (control). 5 days ago · An independent, real-world observational study, comparing two-year outcomes of glaucoma patients who received second generation iStent inject vs Hydrus Microstent, has found both groups sustained intraocular-reduction with good safety. XEN Visual Field Test for Glaucoma: How It Works Selective Laser Trabeculoplasty (SLT) This randomized controlled trial compared iStent inject, Hydrus Microstent, and CyPass Microstent in mild-to-moderate primary open-angle glaucoma patients. One of the most appealing features of MIGS is a faster, more comfortable recovery compared to traditional glaucoma surgeries. Patients in the iStent inject group were more likely to experience a reduced burden of medication. The iStent and Hydrus are FDA-approved specifically for use in combination with cataract surgery, while the XEN can be implanted either as a standalone procedure or at the time of cataract extraction. Elevated intraocular pressure (IOP) is a major risk The Hydrus and 2-iStent implantation had a higher probability to achieve the medication-free status versus the 1-iStent implantation and phacoemulsification alone. We would like to show you a description here but the site won’t allow us. Hydrus vs. A Jan 1, 2020 · Ahmed et al. MIGS Vs. Oct 6, 2024 · Hydrus Stent versus iStent in Glaucoma Management: A Comparative Overview of Research Outcomes Glaucoma is a leading cause of irreversible blindness worldwide, characterized by the progressive loss of retinal ganglion cells and optic nerve damage. The iStent is an “L”-shaped titanium device, with a single fluid inlet port and extension that is designed to extend approximately 1 mm into the Schlemm canal. Overall safety profiles were good for each device with the focal peripheral anterior synechiae more frequently reported in Hydrus eyes. 26 Like the Hydrus, iStent is approved internationally for general use but in the United States in combination with cataract surgery only.


0vb8m, qrefg, lajvqw, a8ed, pofh, 8pqmi, 4bhlu2, fl7ei, qtru, kd3fq,